BHC EBITDA Growth
Bausch Health Companies Inc. Common Stock · EBITDA Growth
BHC EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-37.34%period ending
BHC TTM EBITDA YoY % (-200.00% → -37.34%)
Year-over-year change
High-resolution chart · PNG
BHC ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -37.3431% | |
| -37.5928% | |
| 1.5655% | |
| 8.8744% | |
| 9.1182% | |
| 5.0426% | |
| 8.7851% | |
| 8.3333% | |
| 9.7366% | |
| 10.8643% | |
| 2.7906% | |
| -1.3559% | |
| -8.229% | |
| -13.375% | |
| -12.2258% | |
| -10.5669% | |
| -10.6133% | |
| -3.1831% | |
| 1.1097% | |
| 2.3293% | |
| 6.808% | |
| -5.6217% | |
| -7.2626% | |
| -6.8371% | |
| -6.9058% | |
| 0.0893% | |
| 2.4398% | |
| 0.5981% | |
| -0.5057% | |
| -1.2349% | |
| -2.7249% | |
| -6.5184% | |
| -11.1329% | |
| -13.1773% | |
| -16.043% | |
| -20.5584% | |
| -21.2085% | |
| -23.3264% | |
| -22.1365% | |
| -9.4894% | |
| 5.2891% | |
| 22.8396% | |
| 31.1817% | |
| 31.0883% | |
| 11.3123% | |
| 10.8431% | |
| 14.3041% | |
| 25.0631% | |
| 104.027% | |
| 115.8868% | |
| 142.1578% | |
| 176.5629% | |
| 84.0456% | |
| 67.7335% | |
| 54.2587% | |
| 44.7183% | |
| 167.3532% | |
| 319.3864% | |
| 808.9392% | |
| 386.3455% | |
| 15.687% | |
| -24.4721% | |
| -70.6247% | |
| -51.2551% | |
| 18.2023% | |
| 13.7969% | |
| 17.1428% | |
| 48.1096% | |
| 37.9578% | |
| 12.3411% | |
| 2.957% | |
| -52.3461% | |
| -36.7333% | |
| -30.0481% | |
| -17.2331% | |
| 47.4772% | |
| -30.4369% | |
| -16.4777% | |
| -7.5488% | |
| -7.0102% | |
| 88.134% | |
| 55.9051% | |
| 26.0314% | |
| 70.9629% | |
| 36.0538% | |
| 10.5015% | |
| -3.1385% | |
| -58.3376% | |
| -60.7173% | |
| -42.1684% | |
| -20.9511% | |
| 22.4873% | |
| 38.7231% | |
| 32.7429% | |
| 22.688% | |
| 34.3586% | |
| 44.3628% | |
| 69.1935% | |
| 107.8169% | |
| 129.5402% |